Cargando…
Patterns and predictors of long-term retention of inflammatory bowel or rheumatoid disease patients on innovator infliximab: an analysis of a Canadian prescriptions claims database
BACKGROUND: Long-term effectiveness is an important factor when considering treatment decisions. OBJECTIVE: To determine the long-term retention patterns of Canadian inflammatory bowel disease (IBD) and rheumatologic disease (RD) patients, including rheumatoid arthritis, psoriatic arthritis, and ank...
Autores principales: | Baer, Philip A, Aumais, Guy, Ewara, Emmanuel M, Khraishi, Majed, Marrache, A Marilise, Panaccione, Remo, Wade, John P, Marshall, John K |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6154729/ https://www.ncbi.nlm.nih.gov/pubmed/30271124 http://dx.doi.org/10.2147/PPA.S171363 |
Ejemplares similares
-
Patterns and predictors of long-term retention of inflammatory bowel or rheumatoid disease patients on innovator infliximab: an analysis of a Canadian prescriptions claims database [Erratum]
Publicado: (2018) -
Reduction in the utilization of prednisone or methotrexate in Canadian claims data following initiation of etanercept in pediatric patients with juvenile idiopathic arthritis
por: Khraishi, Majed, et al.
Publicado: (2019) -
Long-term effectiveness and safety of infliximab, golimumab and ustekinumab in patients with psoriatic arthritis from a Canadian prospective observational registry
por: Rahman, Proton, et al.
Publicado: (2020) -
A Review of the Totality of Evidence for the Development and Approval of ABP 710 (AVSOLA), an Infliximab Biosimilar
por: Reinisch, Walter, et al.
Publicado: (2021) -
Long-term effectiveness and safety of infliximab, golimumab and golimumab-IV in rheumatoid arthritis patients from a Canadian prospective observational registry
por: Rahman, Proton, et al.
Publicado: (2020)